Insights into inflammation and immunology
The new Centre for Inflammation Biology & Cancer Immunology (CIBCI) was officially launched last month with a celebratory showcase event.
CIBCI is an interdisciplinary research hub that brings together basic and clinical scientists from the School of Immunology & Microbial Sciences and other King’s College London researchers working on inflammation biology and cancer immunology.
The guiding mission of the Centre is to enhance the fundamental and applied knowledge of inflammation biology, tumour immunobiology, and their bearing upon each other.
[Image: President & Principal Professor Ed Byrne and Professor Leonie Taams unveiling the plaque symbolising the opening for the Centre for Inflammation Biology & Cancer Immunology]
CIBCI aspires to provide new insights into the understanding, diagnosis and treatment of inflammation, its associated pathologies, and its contribution to tumour immunobiology. The collective aim is to identify key mechanisms and pathways underlying inflammation and cancer and to open new opportunities to innovative treatment of human disease.
The Centre was officially opened by King’s College London President & Principal, Professor Edward Byrne AC, who unveiled a plaque with Professor Leonie Taams, Director of CIBCI and Head of Department of Inflammation Biology. Attendees included colleagues from across King’s Health Partners, representatives from funding bodies, charities, pharmaceutical industry and biotech companies, as well as patients.
Of the research carried out by CIBCI, Professor Taams commented:
This is a highly exciting time to work in inflammation biology and cancer immunology. Increasingly, we can translate insights from basic scientific studies of immune cells into potential therapies that may transform the lives of people living with inflammatory diseases or cancer.
Read more on the King’s College London website.
As a European Comprehensive Cancer Centre, the King's Health Partners Cancer Clinical Academic Group brings together world-class clinical services, research and education for the benefit of cancer patients in south east London and beyond.
The King’s Health Partners Genetics, Rheumatology, Infection, Immunology and Dermatology Clinical Academic Group promotes academic input into the delivery of state-of-the-art clinical services, fuels investigative clinical research, and promotes the translation of basic science discoveries.